A car accident leaves an aging patient with severe muscle injuries that won’t heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method may help change this.
Researchers at the Georgia Institute of Technology engineered a molecular matrix, a hydrogel, to deliver muscle stem cells called muscle satellite cells (MuSCs) directly to injured muscle tissue in patients whose muscles don’t regenerate well. In lab experiments on mice, the hydrogel successfully delivered MuSCs to injured, aged muscle tissue to boost the healing process while protecting the stem cells from harsh immune reactions.
The method was also successful in mice with a muscle tissue deficiency that emulated Duchene muscular dystrophy, and if research progresses, the new hydrogel therapy could one day save the lives of people suffering from the disease.
Inflammatory war zone
Simply injecting additional muscle satellite cells into damaged, inflamed tissue has proven inefficient, in part because the stem cells encounter an immune system on the warpath.
“Any muscle injury is going to attract immune cells. Typically, this would help muscle stem cells repair damage. But in aged or dystrophic muscles, immune cells lead to the release a lot of toxic chemicals like cytokines and free radicals that kill the new stem cells,” said Young Jang, an assistant professor in Georgia Tech’s School of Biological Sciences and one of the study’s principal investigators.
Only between 1 and 20 percent of injected MuSCs make it to damaged tissue, and those that do, arrive there weakened. Also, some tissue damage makes any injection unfeasible, thus the need for new delivery strategies.
“Our new hydrogel protects the stem cells, which multiply and thrive inside the matrix. The gel is applied to injured muscle, and the cells engraft onto the tissues and help them heal,” said Woojin Han, a postdoctoral researcher in Georgia Tech’s School of Mechanical Engineering and the paper’s first author.
Han, Jang and Andres Garcia, the study’s other principal investigator, published their results on August 15, 2018, in the journal Science Advances. The National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health funded the research.
Hydrogel: watery nets
Hydrogels often start out as water-based solutions of molecular components that resemble crosses, and other components that make the ends of the crosses attach to each other. When the components come together, they fuse into molecular nets suspended in water, resulting in a material with the consistency of a gel.
If stem cells or a drug are mixed into the solution, when the net, or matrix, forms, it ensnares the treatment for delivery and protects the payload from death or dissipation in the body. Researchers can easily and reliably synthesize hydrogels and also custom-engineer them by tweaking their components, as the Georgia Tech researchers did in this hydrogel.
“It physically traps the muscle satellite cells in a net, but the cells also grab onto chemical latches we engineered into the net,” Han said.
This hydrogel’s added latches, which bond with proteins protruding from stem cells’ membranes, not only increase the cells’ adhesion to the net but also hinder them from committing suicide. Stem cells tend to kill themselves when they’re detached and free-floating.
The chemical components and the cells are mixed in solution then applied to the injured muscle, where the mixture sets to a matrix-gel patch that glues the stem cells in place. The gel is biocompatible and biodegradable.
“The stem cells keep multiplying and thriving in the gel after it is applied,” Jang said. “Then the hydrogel degrades and leaves behind the cells engrafted onto muscle tissue the way natural stem cells usually would be.”
Stem cell breakdown
In younger, healthier patients, muscle satellite cells are part of the natural healing mechanism.
“Muscle satellite cells are resident stem cells in your skeletal muscles. They live on muscle strands like specks, and they’re key players in making new muscle tissue,” Han said.
“As we age, we lose muscle mass, and the number of satellite cells also decreases. The ones that are left get weaker. It’s a double whammy,” Jang said. “At a very advanced age, a patient stops regenerating muscle altogether.”
“With this system we engineered, we think we can introduce donor cells to enhance the repair mechanism in injured older patients,” Han said. “We also want to get this to work in patients with Duchene muscular dystrophy.”
“Duchene muscular dystrophy is surprisingly frequent,” Jang said. “About 1 in 3,500 boys get it. They eventually get respiratory defects that lead to death, so we hope to be able to use this to rebuild their diaphragm muscles.”
If the method goes to clinical trials, researchers will likely have to work around the potential for donor cell rejection in human patients.
The Latest on: Muscle stem cells
via Google News
The Latest on: Muscle stem cells
- Q&A: Growing Steaks in the Labon January 31, 2020 at 1:21 pm
We use myoblasts—stem cells that are already committed to turning into muscle cells. Once the solution has permeated the scaffolding, we turn the stem cells into muscle cells by tweaking the nutrients ...
- Mohap and Osaka University join hands to use stem cells for repairing and regenerating heart muscleon January 30, 2020 at 1:51 am
MoHAP added that the project is still underway in partnership with Osaka University, Japan. Based on tissue engineering, cells were produced after being grown in specialized human incubators to repair ...
- Lab-grown heart cells implanted into human patient for the first timeon January 29, 2020 at 5:46 pm
The clinical trial harnesses the incredible potential of induced pluripotent stem cells (IPSCs), a Nobel Prize-winning technology developed ... who has been developing a technique to turn IPSCs into ...
- University of Michigan stem cell research has implications for anti-cancer treatmentson January 29, 2020 at 1:40 pm
Through using mouse embryonic stem cells, the team found that by delaying WDR5, cells emerging from stem cells, developed from possible nervous system tissues into mesodern -- an embryonic layer that ...
- 1 number could make the hunt for cancer cells easieron January 29, 2020 at 10:23 am
Cells that initiate cancer are thought to be stem cells, hard-to-find cells that can reproduce themselves and develop, or differentiate, into more specialized tissue, such as skin or muscle—or, when ...
- Lab-grown heart muscles transplanted into a human for the first timeon January 29, 2020 at 6:25 am
Researchers in Japan have successfully carried out the world's first transplant of lab-grown heart muscle cells, in a move which could significantly reduce the need for heart transplants. To grow the ...
- First Ever Lab-Grown Heart Muscle Transplant Successfully Carried Out In Japanon January 29, 2020 at 5:29 am
The clinical trial used induced pluripotent stem cells (iPS) – a kind of “master cell” that can turn into any cell type – derived from healthy donors’ blood cells. The iPS were then used in the large ...
- Researchers Transplant Lab-Grown Heart Muscle Cells Into Patienton January 28, 2020 at 4:26 pm
To create the heart muscle cells, the team started with induced pluripotent stem (iPS) cells. These are stem cells that researchers create by taking an adult’s cells — often from their skin or blood — ...
- Osaka University transplants iPS cell-based heart cells in world's first clinical trialon January 27, 2020 at 11:43 pm
OSAKA – An Osaka University team said it has carried out the world’s first transplant of cardiac muscle cells created from iPS cells in a physician-initiated clinical trial. In the clinical project to ...
- First heart surgery performed using iPS cellson January 27, 2020 at 2:51 am
A Japanese group of researchers says it has conducted heart surgery using sheets of heart muscle cells made from iPS cells. Induced pluripotent stem cells are created from reprogrammed human cells and ...
via Bing News